-
-
Name
- Mersacidin(M87-1551)
-
Sequence
- CTFTLPGGGGVCTLTSECIC
-
Description
- Mersacidin is a type-B lantibiotic containing 3-methyllanthionine and S-(2-aminovinyl)-3-methylcysteine residues and four intra-chain thioether bridges. It is obtained from Bacillus sp. HIL Y-85,54728 and is active in vivo against methicillin-resistant Staphylococcus aureus (MRSA). It has a role as a metabolite and an antibacterial agent. It is a type B lantibiotic and a macrocycle. It is a tautomer of a mersacidin zwitterion.
-
-
Target Organism
-
- No MICs found on DRAMP database
-
-
Medical use
- Gram-positive infections,MRSA
-
Company
- Novacta Biosystems Ltd.(Hatfield, England)
-
Stage of Development
- Preclinical
-
-